Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.35NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.1.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XAY.2.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XAY.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAY.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAY.2.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CH.1.1.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CH.1.1.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.36ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.36ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.36NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BV.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BV.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BV.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BV.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.26ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.26NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.33ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.1.33ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.33NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CP.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CP.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CP.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.45ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.45ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.45ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.45NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.5.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.5.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.5.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.5.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.41ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used